(MENAFN- GlobeNewsWire - Nasdaq) The compounding pharmacies market thrives on the demand for customized medications, supporting trends in personalized medicine. Key opportunities lie in innovative drug delivery systems, integrating retail services, and expanding hormone therapy offerings, especially in aging populations. The U.S., Germany, and Australia lead potential regional growth.

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Compounding Pharmacies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)" report has been added to ResearchAndMarkets's offering.

Global compounding pharmacies market is projected to rise from US$ 10.9 billion in 2025 to US$ 17 billion by 2032, registering a CAGR of 6.56% during the forecast period.

The increasing awareness about personalized treatment regimens, combined with advancements in compounding technology and drug formulation, is expected to elevate the market trajectory in the coming years.
The compounding pharmacies market is gaining significant traction worldwide due to the growing need for customized medications tailored to individual patient requirements. These specialized pharmacies play a critical role in preparing personalized formulations when commercially available drugs fail to meet patient-specific needs, including allergy issues, unique dosage forms, or flavor preferences. As healthcare trends continue to shift toward personalized medicine, compounding pharmacies are emerging as a crucial component of the pharmaceutical supply chain.
Market Drivers
One of the primary drivers of the compounding pharmacies market is the rise in chronic conditions requiring individualized treatment plans. Patients with allergies to specific dyes or fillers, pediatric and geriatric patients needing specialized dosage forms, and individuals on specific dietary restrictions increasingly rely on compounded medications. Additionally, the global shortage of certain commercially available drugs has further fueled demand for compounded alternatives.
Hormone replacement therapy (HRT) is another significant contributor to market growth. With increasing awareness of hormonal imbalances and associated conditions such as menopause, erectile dysfunction, and infertility, the use of compounded hormone therapies has surged. These therapies allow patients to receive customized doses not typically available in mass-manufactured pharmaceuticals.
Business Opportunity
The market offers lucrative growth opportunities, especially in the development of innovative drug delivery systems. From flavored liquid medications for children to lollipops and topical formulations for dermatology and pain management, compounding pharmacies are expanding the boundaries of patient-friendly dosage forms. Partnerships with local manufacturers and strategic acquisitions are enabling key players to enhance their reach and product portfolios.
Moreover, the trend of integrating retail and compounding services within pharmacies is gaining momentum. This hybrid model boosts revenue potential while also offering convenience to patients. Market players are also capitalizing on the rising demand for bio-identical hormone replacement therapy (BHRT), particularly in regions with aging populations, to further expand their product offerings.
Region Analysis
The United States remains the dominant market for compounding pharmacies, attributed to its advanced healthcare infrastructure, rising prevalence of dermatological and chronic diseases, and high demand for customized medications. The increasing popularity of online compounding services and bio-identical hormone therapies is further contributing to market expansion in the region.
Germany is emerging as a key European market, driven by its rapidly aging population and growing demand for customized anti-aging and hormonal treatments. With projections indicating a significant increase in the elderly population by 2050, the need for tailored medications is expected to grow substantially.
Australia is also gaining recognition as a promising market, with growing interest in hormone-related therapies and an increasing number of patients seeking personalized treatment regimens. Compounding pharmacists are playing a vital role in supporting menopausal women through customized BHRT solutions.
Key Players

These companies are focused on strategic collaborations, product innovation, and regional expansion to strengthen their market presence. Notable developments include new facility launches, mergers with raw material suppliers, and technological advancements in dosage form delivery.

• Fagron
• Fresenius Kabi AG
• PharMEDium Services LLC
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Lorraine's Pharmacy
• B.Braun Melsungen AG Company

Segmentation

By Product:

• Oral Medication
• Capsules
• Tablets
• Mixtures
• Lollipops
• Lozenges
• Topical Medications
• Gels
• Ointments
• Creams
• Lotions
• Mouthwashes
• Suppositories

By Application:

• Medication for Adults
• Medication for Children
• Medication for Geriatric
• Medication for Veterinary

By Therapeutic Area:

• Pain Management
• Hormone Replacement Therapy

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN08102025004107003653ID1110167174